GENEVA, July 29 (Reuters) - Bird flu vaccine developer Sinergium Biotech will share its data with manufacturers in low and middle-income countries to help to accelerate a fair rollout if a pandemic occurs, the World Health Organization said on Monday.
The Argentine private sector biopharmaceutical company is at an early stage of developing mRNA vaccines against the H5N1 virus and has pledged to share its findings with a
network of partner manufacturers set up by the WHO during the peak of COVID-19 to help poorer countries to gain access to life-saving medical tools.
